New York State Common Retirement Fund’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-39,604
| Closed | -$1.62M | – | 3405 |
|
|
2024
Q2 | $1.62M | Buy |
39,604
+11,025
| +39% | +$451K | ﹤0.01% | 1547 |
|
|
2024
Q1 | $1.21M | Buy |
28,579
+44
| +0.2% | +$1.86K | ﹤0.01% | 1690 |
|
|
2023
Q4 | $1.21M | Buy |
28,535
+1,383
| +5% | +$58.6K | ﹤0.01% | 1699 |
|
|
2023
Q3 | $593K | Buy |
27,152
+207
| +0.8% | +$4.52K | ﹤0.01% | 1983 |
|
|
2023
Q2 | $857K | Sell |
26,945
-3,542
| -12% | -$113K | ﹤0.01% | 1848 |
|
|
2023
Q1 | $744K | Sell |
30,487
-10,684
| -26% | -$261K | ﹤0.01% | 1970 |
|
|
2022
Q4 | $1.3M | Buy |
41,171
+19
| +0% | +$599 | ﹤0.01% | 1841 |
|
|
2022
Q3 | $1.16M | Buy |
41,152
+3,146
| +8% | +$88.9K | ﹤0.01% | 1894 |
|
|
2022
Q2 | $1.01M | Buy |
38,006
+7,552
| +25% | +$200K | ﹤0.01% | 2012 |
|
|
2022
Q1 | $1.07M | Buy |
30,454
+1,928
| +7% | +$67.5K | ﹤0.01% | 2076 |
|
|
2021
Q4 | $925K | Buy |
28,526
+3,059
| +12% | +$99.2K | ﹤0.01% | 2138 |
|
|
2021
Q3 | $751K | Sell |
25,467
-4,733
| -16% | -$140K | ﹤0.01% | 2248 |
|
|
2021
Q2 | $774K | Buy |
+30,200
| New | +$774K | ﹤0.01% | 2348 |
|